Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
Go back to Eliquis, Orencia sales propel Bristol-Myers to strong second quarter| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 60.84 -0.84 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.68 | 52 Week High | $77.12 | |||
| Open | $61.50 | 52 Week Low | $49.03 | |||
| Day High | $61.81 | P/E | 39.51 | |||
| Day Low | $60.80 | EPS | $1.54 | |||
| Volume | 2,024,064 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 148.48 +0.18 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.30 | 52 Week High | $65.46 | |||
| Open | $147.11 | 52 Week Low | $47.97 | |||
| Day High | $149.44 | P/E | 101.01 | |||
| Day Low | $147.11 | EPS | $1.47 | |||
| Volume | 2,699,955 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 29.76 -0.35 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.11 | 52 Week High | $37.39 | |||
| Open | $30.00 | 52 Week Low | $28.25 | |||
| Day High | $30.09 | P/E | 18.04 | |||
| Day Low | $29.73 | EPS | $1.65 | |||
| Volume | 6,194,438 | |||||



